New at-home STI tests and treatments could accelerate declining infection rates in the US

New at-home tests and treatments for common STIs are available, potentially driving further reductions in infection rates. The FDA approved the first home tests for gonorrhea, chlamydia, and trichomoniasis, along with a kit for the HPV virus. Two new oral medications for gonorrhea were also approved. These advancements arrive as STI rates have been declining, though concerns remain about accessibility and tracking due to costs and public health funding cuts.